(Q50559921)
Statements
Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts (English)
Mikko A I Keränen
Bronislaw Pytowski
Antti I Nykänen
Henrik Sandelin
Raimo Tuuminen
Terhi Kärpänen
Yan Wu
Petri K Koskinen